In animal models, intraperitoneal injection of AQP4-IgG in the context of T cell-mediated brain inflammation or intracerebral co-injection of AQP4-IgG and complement induced NMO-like lesions [16–18]. Here, AQP4 is linked to brain inflammatory disease.